imeqrd.co.jp

What It Is

アイメックRD（株式会社アイメックRD） is not a SaaS product in the traditional sense. It is a Japan-based medical and healthcare CRO/R&D outsourcing provider focused on “end-to-end support from clinical trials to specialized R&D needs.” Its work centers on non-public-insurance health sectors such as foods, supplements, cosmetics, health devices, and digital health services. The company helps clients generate scientific evidence through human studies and supports Japan-specific application pathways such as Foods with Function Claims and Foods for Specified Health Uses.

Core Capabilities

Based on the main content, its services cover everything from turning research ideas into concrete plans, feasibility studies, trial design, protocol development, IRB ethics review, participant recruitment, trial execution, data management/QC, statistical analysis, report preparation, and decision-making support. The company emphasizes assigning a dedicated project team to each client, with the same team following the project from kickoff through final reporting. It also leverages a network of physicians, universities, research institutions, and medical institutions to support a wide range of evaluation areas, including immunity, stress, eye function, metabolism, skin, sleep, gut microbiota, and metabolomics.

Pricing and Delivery

The official website does not list standard packages; pricing is project-based. Costs depend on the number of participants, trial design complexity, test items, and project duration. Basic quotations are free, and paid options that include academic research can also be provided. An example payment structure is roughly 50% upfront at contract signing, around 50% upon data delivery, and settlement of analysis/reporting fees upon delivery of the final report. Specific terms are negotiable.

Pros and Cons

Its strengths include more than 20 years of clinical trial/SMO experience, a relatively complete clinical trial execution workflow, IRB and ethics compliance capabilities, NDA support, and familiarity with Japan’s functional food application pathways. The limitations are also clear: this is not an online software platform that can be activated immediately, and it does not offer SaaS features such as APIs, user permissions, or cloud deployment. Pricing must be confirmed through consultation. At present, it only supports clinical trials within Japan, and new outsourced pharmaceutical clinical trial projects have largely been discontinued.

Best Fit and Access from China

It is best suited to companies planning to verify efficacy or prepare regulatory applications for foods, supplements, or health services in the Japanese market, as well as R&D teams that need Japanese participant data and local compliance support. Chinese companies targeting registration or testing in China should evaluate domestic CRO or testing-institution alternatives. If the goal is Japan’s Foods with Function Claims or FOSHU application process, however, its local network may be more valuable. The main content does not disclose website accessibility from China or payment convenience, so these remain unknown.